InvestorsHub Logo
Followers 55
Posts 7281
Boards Moderated 0
Alias Born 08/16/2011

Re: None

Monday, 06/04/2018 10:19:49 AM

Monday, June 04, 2018 10:19:49 AM

Post# of 290
Most of the concerns are based upon a very small Phase 2 group and no control group. Yet they are still moving forward with Phase 3 trials.


https://www.forbes.com/sites/matthewherper/2018/06/02/nektar-and-bristol-hurtle-forward-with-experimental-cancer-drug/#6986c24445b6

I wouldn't try to catch the falling knife today but over the next 90 days I think the stock will recover up to the 70 area.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NKTR News